CNBT
CRL icon

Canandaigua National Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Canandaigua National Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,131
Closed -$234K – 339
2024
Q2 		$234K Sell
1,131
-6
-0.5% -$1.36K 0.03% 285
2024
Q1 		$308K Sell
1,137
-20
-2% -$4.78K 0.05% 214
2023
Q4 		$274K Sell
1,157
-17
-1% -$3.34K 0.04% 219
2023
Q3 		$230K Sell
1,174
-35
-3% -$7.19K 0.04% 236
2023
Q2 		$254K Sell
1,209
-13
-1% -$2.59K 0.04% 228
2023
Q1 		$247K Buy
+1,222
New +$277K 0.04% 227
2020
Q1 		$250K Sell
1,980
-167
-8% -$25K 0.05% 209
2019
Q4 		$328K Sell
2,147
-50
-2% -$6.92K 0.06% 209
2019
Q3 		$291K Sell
2,197
-63
-3% -$8.45K 0.05% 218
2019
Q2 		$321K Sell
2,260
-95
-4% -$12.9K 0.06% 208
2019
Q1 		$342K Sell
2,355
-255
-10% -$33.5K 0.07% 195
2018
Q4 		$295K Sell
2,610
-435
-14% -$54.5K 0.06% 210
2018
Q3 		$410K Sell
3,045
-74
-2% -$9.13K 0.07% 187
2018
Q2 		$350K Buy
3,119
+23
+0.7% +$2.49K 0.07% 215
2018
Q1 		$330K Buy
+3,096
New +$334K 0.04% 275

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Canandaigua National Bank & Trust's CRL Position: Q3 2024 in Review

Canandaigua National Bank & Trust sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 1,131 shares — an estimated $234K sold.

Canandaigua National Bank & Trust first reported a position in CRL in Q1 2018 and held it in 15 quarters. The position peaked at $410K in Q3 2018. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Canandaigua National Bank & Trust reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 1,131 Charles River Laboratories shares in Q3 2024, an estimated $234K.
  • Canandaigua National Bank & Trust first reported a position in Charles River Laboratories in Q1 2018 and held it in 15 quarters.
  • Canandaigua National Bank & Trust's Charles River Laboratories position peaked at $410K in Q3 2018.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2024, filed 3 Oct 2024.